Diagnosis of severe respiratory infections in immunocompromised patients
Élie Azoulay(Hôpital Saint-Louis), José Garnacho‐Montero(Hospital Universitario Virgen Macarena), Ignacio Martín‐Loeches(St. James's Hospital), Djamel Mokart(Inserm), Lene Russell(University of Copenhagen), Victoria Metaxa(Apple (Israel)), Jordi Rello(Centre Hospitalier Universitaire de Montpellier), Philippe R. Bauer(Mayo Clinic in Florida), Andry Van de Louw(Penn State Milton S. Hershey Medical Center), Adrien Mirouse(Assistance Publique – Hôpitaux de Paris), Pedro Póvoa(University of Lisbon), Virginie Lemiale(Université Paris Cité), Sangeeta Mehta(University of Toronto), Kathryn Puxty(NHS Greater Glasgow and Clyde), Peter Schellongowski(Charles University)
Cited by 340
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure
|European Respiratory Journal|2017|1.7k
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
|CHEST Journal|2002|1.3k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k